Nateglinide does not stop progression in diabetes

March 2010
Pulse;3/24/2010, Vol. 70 Issue 10, p9
The article reports on the claims that Nateglinide cannot prevent the progression of diabetes in the study lead by University of Oxford Diabetes Trials director and professor Rury Holman.


Related Articles

  • 'Difficult' diabetes targets are feasible, UKPDS reveals. Pedder, Cato // Pulse;3/22/2004, Vol. 64 Issue 12, p2 

    Details the claim of Professor Rury Holman, a diabetes expert, that general practitioners (GP) will be able to meet challenging diabetes targets in the GMS contract only by monitoring hypertensive diabetes and using combination therapy more widely. Drop in blood pressure levels in type 2...

  • Long-term gains from early diabetes treatment. Pickett, Sharon // GP: General Practitioner;9/12/2008, p7 

    The article reports on the result of the study on the long term benefits of early treatment for diabetes by the United Kingdom Prospective Diabetes Study (UKPDS). The UKPDS trial has 5,102 patients tracked from 1977 to 1997 reveals that complications of diabetes may lessen by improving blood...

  • Experts call for improved reporting, better clinical trials.  // Endocrine Today;Nov2011, Vol. 9 Issue 11, p23 

    The article highlights the views of experts, such as Rury R. Holman, on the need for a systematic approach to assess clinical trials and improve reporting of clinical trial findings.

  • Bladder Ca Worse in Diabetics.  // Renal & Urology News;Feb2012, Vol. 11 Issue 2, p17 

    The article reports on the association of diabetes mellitus and disease recurrence and progression among patients who have undergone surgery for non-muscle invasive bladder cancer.

  • Response to Comment on Anjana et al. Incidence of Diabetes and Prediabetes and Predictors of Progression Among Asian Indians: 10-Year Follow-up of the Chennai Urban Rural Epidemiology Study (CURES). Diabetes Care 2015;38:1441-1448. Anjana, Ranjit Mohan; Deepa, Mohan; Mohan, Viswanathan // Diabetes Care;Dec2015, Vol. 38 Issue 12, pe212 

    A response to an article about predictors of progression to diabetes and prediabetes among Asian Indian which appeared within the issue is presented.

  • Diabetic Nephropathy: Preventing Progression. Shlipak, Michael // American Family Physician;3/15/2011, Vol. 83 Issue 6, p732 

    The article presents an excerpt from the "Clinical Evidence Handbook" published by the BMJ Publishing Group which discusses how to prevent the progression of diabetic nephropathy.

  • Weight stabilization in adolescents with prediabetes halts transition to diabetes.  // Endocrine Today;Jun2014, Vol. 12 Issue 6, p17 

    The article focuses on study which revealed the significant role of weight stabilization in preventing diabetes progression in prediabetic adolescents.

  • Diabetische Nephropathie - Update 2012. Auinger, Martin; Edlinger, Roland; Prischl, Friedrich; Kautzky-Willer, Alexandra; Prager, Rudolf; Rosenkranz, Alexander R.; Roden, Michael; Saemann, Marcus; Clodi, Martin; Schernthaner, Guntram // Wiener Klinische Wochenschrift;Dec2012 Supplement, Vol. 124, p42 

    Diabetes mellitus is the leading single cause for renal replacement therapy. Its development and progression, however, can be ameliorated by adequate therapy. The present article represents the recommendations of the Austrian Diabetes Association and the Austrian Society for Nephrology for the...

  • Progression and regression of microalbuminuria in type 1 diabetes. Close, Colin // Diabetes Digest;2011, Vol. 10 Issue 3, p160 

    The article discusses the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DDCT/EDIC) cohort study on the regression of microalbuminuria in type 1 diabetes. It says that regression occurs in 40% of the participants, which is associated with lower...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics